NEW YORK (GenomeWeb) – Despite their efficacy as gene-editing technologies, CRISPR/Cas9 and TALENs are still hampered by the potential for off-target activity, which can result in genome instability and impair normal gene function. But a new strategy reported this week, which had previously been developed for a related technology, promises to help researchers measure such unintended effects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.